journal article·2024-03

Injectable alginate-based in situ self-healable transparent hydrogel as a vitreous substitute with a tamponading function

Geunho Choi, Seoung Hyun An, Jae-Won Choi, Mee Sook Rho, Woo Chan Park, Woo jin Jeong, Hyung Joon Cha

Biomaterials· Volume 305
Publisher page

Abstract

Retinal detachment and other vision-threatening disorders often necessitate vitreous body removal and tamponade injection for retina stabilization. Current clinical tamponades such as silicone oil and expansile gases have drawbacks, including patient discomfort and the need for secondary surgery. We introduce a transparent alginate-phenylboronic acid/polyvinyl alcohol composite hydrogel (TALPPH) as a novel vitreous substitute with tamponading capabilities. In vitro physicochemical, rheological, and optical characterization of in situ self-healable TALPPH was performed, and long-term biocompatibility was assessed in a rabbit model of vitrectomy retinal detachment. In vivo evaluations confirmed TALPPH's ability to inhibit retinal detachment recurrence and preserve rabbit vision without adverse effects. TALPPH's close resemblance to the natural vitreous body suggests potential as a vitreous tamponade substitute for future ophthalmological applications.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Retinal and Macular Surgery · Intracranial Aneurysms: Treatment and Complications · Corneal Surgery and Treatments

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (58)

Show source-provided references
1. Proteomic analysis of human vitreous humor
2. Recent advances in polymeric vitreous substitutes10.1586/17469899.2.2.255 ↗
3. IB hyaluronan and other Carbohydrates in the vitreus, vitreous
4. Importance of vitreous liquefaction in age-related cataract10.1167/iovs.03-0820 ↗
5. Vitreous substitutes: a comprehensive review10.1016/j.survophthal.2010.09.001 ↗
6. Pathology and pathogenesis of retinal detachment10.1038/sj.eye.6700197 ↗
7. Different mechanistic association of myopia with rhegmatogenous retinal detachment between young and elderly patients10.1155/2019/5357241 ↗
8. Retinal detachment in developing countries10.1038/sj.eye.6700188 ↗
9. Efficacy of two different thiol-modified crosslinked hyaluronate formulations as vitreous replacement compared to silicone oil in a model of retinal detachment10.1371/journal.pone.0172895 ↗
10. Anterior segment complications related to vitreous substitutes10.1016/j.ohc.2004.06.011 ↗
11. Heavy tamponade 1: a review of indications, use, and complications10.1038/eye.2008.61 ↗
12. Evaluation of intraocular gas using magnetic resonance imaging after pars plana vitrectomy with gas tamponade for rhegmatogenous retinal detachment10.1038/s41598-020-58508-3 ↗
13. Wilkinson · 1996 · 391
14. The biocompatibility of silicone, fluorosilicone and perfluorocarbon liquids as vitreous tamponades an ultrastructural and immunohistochemical study10.1159/000050874 ↗
15. Artificial vitreous body: strategies for vitreous body substitutes10.1007/s00347-015-0057-z ↗
16. Towards an ideal biomaterial for vitreous replacement: historical overview and future trends10.1016/j.actbio.2010.10.030 ↗
17. Polymeric hydrogels as a vitreous replacement strategy in the eye10.1016/j.biomaterials.2020.120547 ↗
18. Use of perfluorohexyloctane as a long-term internal tamponade agent in complicated retinal detachment surgery10.1016/S0002-9394(01)01295-8 ↗
19. Polymers of 1-vinyl-2-pyrrolidinone as potential vitreous substitutes: physical selection10.1177/088532829601100202 ↗
20. Characterization of silk-hyaluronic acid composite hydrogels towards vitreous humor substitutes10.1016/j.biomaterials.2019.119729 ↗
21. Glutathione improves the antioxidant activity of vitamin C in human lens and retinal epithelial cells: implications for vitreous substitutes10.1080/02713683.2020.1809002 ↗
22. Stable oxime-crosslinked hyaluronan-based hydrogel as a biomimetic vitreous substitute10.1016/j.biomaterials.2021.120750 ↗
23. Retinal-detachment repair and vitreous-like-body reformation via a thermogelling polymer endotamponade10.1038/s41551-019-0382-7 ↗
24. Fast-forming hydrogel with ultralow polymeric content as an artificial vitreous body10.1038/s41551-017-0044 ↗
25. Alginate: properties and biomedical applications10.1016/j.progpolymsci.2011.06.003 ↗
26. Alginate-and hyaluronic acid–based hydrogels as vitreous substitutes: an in vitro evaluation10.1167/tvst.9.13.34 ↗
27. The feasibility study of an in situ marine polysaccharide‐based hydrogel as the vitreous substitute10.1002/jbm.a.36403 ↗
28. Silicone microbubbles after anti‐vascular endothelial growth factor injections in patients with wet age‐related macular degeneration: incidence, quantification and secondary optical coherence tomography artfacts10.1111/aos.14743 ↗
29. Prevalence of silicone oil droplets in eyes treated with intravitreal injection10.1186/s40942-018-0153-8 ↗
30. Prevalence and implications of the presence of intraocular silicone oil droplets in patients treated with intravitreal injections of anti-VEGF10.1186/s12886-022-02536-2 ↗
31. DNA supramolecular hydrogel as a biocompatible artificial vitreous substitute10.1002/admi.202101321 ↗
32. A new highly transparent injectable PHA-based thermogelling vitreous substitute10.1039/C9BM01603A ↗
33. A practical guide to ISO 10993-5: cytotoxicity
34. Mussel adhesive protein fused with cell adhesion recognition motif triggers integrin‐mediated adhesion and signaling for enhanced cell spreading, proliferation, and survival10.1002/jbm.a.32768 ↗
35. ISCEV Standard for full-field clinical electroretinography (2008 update)10.1007/s10633-008-9155-4 ↗
36. An antioxidant self-healing hydrogel for 3D cell cultures10.1039/C9TB02792K ↗
37. Vitreous substitutes: the present and the future10.1155/2014/351804 ↗
38. Refractive changes in silicone oil–filled pseudophakic eyes10.1097/00006982-200502000-00009 ↗
39. The lipofuscin fluorophore A2E mediates blue light-induced damage to retinal pigmented epithelial cells
40. Rheology of the vitreous body. Part I: viscoelasticity of human vitreous
41. Physiology of vitreous surgery10.1007/s00417-008-0980-7 ↗
42. Recent progress in using biomaterials as vitreous substitutes10.1021/acs.biomac.5b01091 ↗
43. Rheological properties and age-related changes of the human vitreous humor10.3389/fbioe.2018.00199 ↗
44. Rabbit models of ocular diseases: new relevance for classical approaches10.2174/1871527315666151110124957 ↗
45. Effect of intraocular silicone oil on ocular tissue
46. Rabbit study of an in situ forming hydrogel vitreous substitute10.1167/iovs.08-2891 ↗
47. Evaluation of viscoelastic poly (ethylene glycol) sols as vitreous substitutes in an experimental vitrectomy model in rabbits10.1016/j.actbio.2010.11.013 ↗
48. Evaluation of an in situ chemically crosslinked hydrogel as a long-term vitreous substitute material10.1016/j.actbio.2012.09.026 ↗
49. Local and systemic effects of unpolymerised monomers
50. TEGDMA-induced oxidative DNA damage and activation of ATM and MAP kinases10.1016/j.biomaterials.2008.12.045 ↗
51. Evaluation of a redox-initiated in situ hydrogel as vitreous substitute10.1016/j.polymer.2014.07.031 ↗
52. Intraocular pressure changes during and after silicone oil endotamponade10.3892/etm.2020.9334 ↗
53. Glaucoma after pars plana vitrectomy and silicone oil injection for complicated retinal detachments10.1016/S0161-6420(99)90017-9 ↗
54. In-situ forming PEG-engineering hydrogels with anti-fouling characteristics as an artificial vitreous body10.1016/j.cej.2022.137486 ↗
55. MIRAgel: hydrolytic degradation and long-term observations10.1001/archopht.125.4.511 ↗
56. Recent advances in hydrogels: ophthalmic applications in cell delivery, vitreous substitutes, and ocular adhesives10.3390/biomedicines9091203 ↗
57. Release of ciprofloxacin from poloxamer-graft-hyaluronic acid hydrogels in vitro10.1016/S0378-5173(03)00259-X ↗
58. In vitro release kinetics of gentamycin from a sodium hyaluronate gel delivery system suitable for the treatment of peripheral vestibular disease10.1081/DDC-100102137 ↗